SDIVX | VIVIX | SDIVX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 26 years | - |
Gain YTD | 14.086 | 16.034 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | N/A | 195B | - |
Annual Yield % from dividends | 5.60 | 2.37 | 237% |
Returns for 1 year | 14.76 | 16.43 | 90% |
Returns for 3 years | -6.14 | 20.48 | -30% |
Returns for 5 years | 9.52 | 44.60 | 21% |
Returns for 10 years | 43.52 | 104.87 | 41% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EMECX | 10.59 | N/A | N/A |
Ashmore Emerging Markets Equity C | |||
SBHIX | 23.14 | -0.13 | -0.56% |
Saratoga Health & Biotechnology I | |||
LAFTX | 19.28 | -0.14 | -0.72% |
Lord Abbett Affiliated R5 | |||
VVSGX | 16.86 | -0.13 | -0.77% |
VALIC Company I Small Cap Growth | |||
OAYEX | 18.17 | -0.21 | -1.14% |
Oakmark International Small Cap Advisor |